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Background: Cavopulmonary blood flow, rather than a systemic arterial source of
pulmonary blood flow, stabilizes Norwood physiology. We hypothesized that pump-
assisted cavopulmonary diversion would yield stable pulmonary and systemic
hemodynamics in the neonate. This was tested in a newborn animal model of total
cavopulmonary diversion and univentricular Fontan circulation.
Methods: Lambs (n  13; mean weight, 5.6  1.5 kg; mean age, 6.8  4.0 days)
were anesthetized and mechanically ventilated. Baseline hemodynamic parameters
were measured. Total cavopulmonary diversion was performed with bicaval ve-
nous-to-main pulmonary artery cannulation. A miniature centrifugal pump was used
to assist cavopulmonary flow. Support was titrated to normal physiologic parame-
ters. Hemodynamic data, arterial blood gases, and lactate values were measured for
8 hours. Baseline, 1-hour, and 8-hour time points were compared by using analysis
of variance.
Results: All animals remained stable without the use of volume loading, inotropic
support, or pulmonary vasodilator therapy. Cardiac index, systemic arterial pressure,
left atrial pressure, and lactate values were similar to baseline values 8 hours after
surgery. Mean pulmonary arterial pressure and pulmonary vascular resistance were
modestly increased 8 hours after surgery. Mean arterial pH, PO2, and PCO2 values
remained stable throughout the study.
Conclusions: Cavopulmonary assist is feasible in a neonatal animal model of total
cavopulmonary diversion and univentricular Fontan circulation with acceptable
pulmonary arterial pressures and without altering regional volume distribution or
cardiac output. Pump-assisted cavopulmonary diversion, in combination with Nor-
wood aortic arch reconstruction, could solve several major problems associated with
a systemic shunt–dependent univentricular circulation, including hypoxemia, im-
paired diastolic coronary perfusion, and ventricular volume overload.
Instability and mortality remain significant problems for palliation of single-ventricle cardiac anomalies. This is especially problematic for stage 1surgical palliation of hypoplastic left heart syndrome, despite refinements intechnique and clinical management.1,2 Interstage mortality, often suddenand unexplained,3,4 ranges from 4% to 24% and is a direct consequence ofan unstable physiologic arrangement. A systemic source of pulmonary
blood flow places the pulmonary and systemic circulations in parallel, and the single
morphologically right ventricle must support twice the normal ventricular volume.
Hypoxemia (PO2 of approximately 35-40 mm Hg), which is mandatory to prevent
pulmonary overcirculation, depresses myocardial and neurocognitive function,5
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stimulates pulmonary hypertension, and prevents normal
involution of the pulmonary arteriolar medial muscle layer.6
The leading identifiable causes of death after the Nor-
wood operation are inadequate coronary blood flow and
either excessive or inadequate pulmonary blood flow, all of
which are directly linked to the systemic-to-pulmonary ar-
terial shunt.7 Coronary perfusion, which normally occurs
predominantly during diastole, shifts to a systolic-predom-
inant pattern because of diastolic shunt runoff and ventric-
ular volume overload and, as such, is further limited by
increased myocardial wall tension.8 The recently described
right ventricle–to-pulmonary artery shunt addresses the im-
portant concern of impaired diastolic coronary perfusion;
however, it does not alleviate the problems of hypoxemia,
parallel circulations, and volume loading of the ventricle,
which may in fact be made worse because of conduit
insufficiency.9
Synthetic shunts have inherent issues, including throm-
bosis and subjectivity in selecting shunt length and diame-
ter.4 Consequently, suboptimal outcomes in stage 1 Nor-
wood physiology are often attributable to shunt-related
problems. In contrast, stability and survival improve dra-
matically in patients after stage 2 and stage 3 palliation of
hypoplastic left heart syndrome, a direct corollary to take-
down of the systemic shunt and establishment of cavopul-
monary blood flow.2
A principal obstacle to combining elements of the sec-
ond- or third-stage procedures (or both) with the first-stage
operation is the potential for increased pulmonary vascular
resistance in the neonate.10 As currently practiced, a high-
pressure source of pulmonary blood flow, via a systemic-
to-pulmonary arterial shunt, is required to overcome poten-
tially increased pulmonary vascular resistance. It stands to
reason that the ability to eliminate the problematic systemic
arterial shunt and instead provide a systemic venous source
of pulmonary blood flow would be of enormous benefit. We
hypothesized that pump-assisted cavopulmonary diversion
would yield stable pulmonary and systemic hemodynamics
and maintain pulmonary gas exchange function in the neo-
nate without altering systemic venous volume distribution
or cardiac output. This concept was tested in a newborn
animal model of total cavopulmonary diversion and univen-
tricular Fontan circulation.
Methods
The experimental protocol was approved by the Animal Care and
Use Committee of the Indiana University School of Medicine.
Animals received humane care in accordance with the Principles
of Laboratory Animal Care formulated by the National Society for
Medical Research and the Guide for the Care and Use of Labo-
ratory Animals prepared by the Institute of Laboratory Animal
Resources and published by the National Institutes of Health
(National Institutes of Health publication 85-23, revised 1985).
Thirteen newborn lambs (mean weight, 5.6  1.5 kg; mean
age, 6.8 days; range, 3 to 15 days) underwent mask induction,
followed by endotracheal intubation and mechanical ventilation
with a Servo 900C volume-cycled respirator (Siemens, Danvers,
Mass) with 100% oxygen and 0.7% to 1.5% isoflurane. Ventilation
was maintained at 32 to 38 breaths per minute with tidal volumes
of 12 to 15 mL/kg and 4 cm H2O positive end-expiratory pressure.
Minor ventilator adjustments were made to maintain a PCO2 of
approximately 35 mm Hg. Temperature was maintained at 38.5°C
with a thermal pad.
A femoral arterial line (Intracath 16 gauge; Becton Dickinson,
Sandy, Utah) was placed for systemic blood pressure monitoring.
A femoral venous line was advanced to the infradiaphragmatic
vena cava for measurement of systemic venous pressure. The heart
was exposed through a median sternotomy, and the pericardium
was suspended. The azygous vein and ductus arteriosus were
ligated. Pressure-monitoring lines were placed in the left atrial
appendage, distal main pulmonary artery, and proximal superior
vena cava. An ultrasonic flowprobe (model 12A; Transonic Sys-
tems Inc, Ithaca, NY) was placed around the ascending aorta.
Baseline systemic arterial pressure, pulmonary arterial pressure,
left atrial pressure, vena caval pressure, and cardiac output were
measured. Baseline activated clotting time, arterial blood gas, and
lactate values were also obtained. Mean circulatory filling pres-
sure, an indicator of unstressed systemic volume status, was mea-
sured in 5 animals by recording inferior vena caval pressure after
7 seconds of induced ventricular fibrillation.11
Total Cavopulmonary Diversion
After systemic heparinization (sodium heparin, 150 U/kg), purse-
string sutures were placed in the superior vena cava, inferior vena
cava, proximal main pulmonary artery, and right atrial appendage.
A decompression cannula (left heart vent catheter, 13F; Medtronic
Inc, Minneapolis, Minn) was introduced through the right atrial
appendage into the right ventricle for egress of thebesian and
coronary venous blood. Bicaval venous (single-stage venous drain-
age cannula, 18F [inferior vena cava] and 14F [superior vena
cava]; Edwards Lifesciences, Irvine, Calif) and pulmonary arterial
cannulation (pulmonary arterial cannula, 18F; A-Med Systems Inc,
West Sacramento, Calif) was performed (Figure 1). The cannulas
were connected to a miniature centrifugal pump (Paraflow; A-Med
Systems Inc), and the circuit was deaired (volume, 45 mL). The
pump was activated, and flow was gradually increased over several
minutes. Pump output was titrated to match baseline cardiac out-
put. Caval occlusion tourniquets were tightened to produce inflow
occlusion to the right heart, and a vascular clamp was placed
across the proximal main pulmonary artery to prohibit right ven-
tricular contribution to pulmonary blood flow.
Fluid Management and Data Acquisition
Intravenous fluids were administered to account for insensible loss
in an open chest animal preparation after major surgical interven-
tion. Additional fluids were administered if inferior vena caval
pressure was lower than baseline or if impaired venous drainage
due to intermittent obstruction was apparent by tugging on the
venous cannulas or by a reduction in pump flow rate without a
change in pump speed. Surgical blood loss was replaced 1:1 with
fresh heparinized homologous blood. Activated clotting time was
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maintained greater than 1.5 times baseline. A surface electrocar-
diogram and systemic arterial waveform were continuously mon-
itored (HP7354C physiologic monitor; Hewlett-Packard, Palo
Alto, Calif). Hemoglobin was measured with an OSM3 he-
moximeter (Radiometer, Westlake, Ohio) calibrated for measure-
ment of sheep hemoglobin. Arterial blood gases, corrected for
hemoglobin level, were measured with an ABL 500 blood gas
analyzer (Radiometer). Arterial lactate values were measured with
a YSI 2300 Stat Plus glucose and lactate analyzer (YSI, Yellow
Springs, Ohio). Hemodynamic data and arterial blood gases were
measured at hourly intervals for 8 hours after initiation of cavo-
pulmonary assist. The postoperative mean circulatory filling pres-
sure was measured at 8 hours (n  5).
Statistical Analysis
Samples are reported as mean  SD. Comparison of baseline
values with 1- and 8-hour time points after initiation of cavopul-
monary assist was performed with analysis of variance. Statistical
analysis was performed with SigmaStat software (SPSS Inc, Chi-
cago, Ill).
Results
Hemodynamic and pulmonary function data are shown in
Table 1. Cardiopulmonary function remained stable
throughout the cavopulmonary assist period without modu-
lation of pulmonary vascular tone, addition of inotropes, or
excessive volume loading. Cardiac index and systolic blood
pressure remained stable throughout the course of the study,
but diastolic blood pressure decreased significantly. Sys-
temic venous pressure and mean circulatory filling pressure
increased only moderately from baseline conditions. This is
an important difference that distinguishes our model from
similar models of univentricular Fontan circulation (without
mechanical assist) in which nonphysiologic volume loading
was necessary to produce hemodynamic stability.12,13
At baseline, pulmonary arterial pressure was expressed
as the mean of pulsatile flow. Because blood flow was
nonpulsatile under cavopulmonary assist conditions, the
absolute pressure was expressed. Pulmonary arterial pres-
sures were modestly increased (mean, 23.3 mm Hg at 8
hours of cavopulmonary assist) when compared with base-
line (13.1 mm Hg), and severe pulmonary hypertensive
events were not encountered. Pulmonary vascular resistance
remained significantly increased from baseline throughout
the cavopulmonary assist period. This value, however,
showed a trend toward normalization and at 8 hours was
significantly lower than values in the early cavopulmonary
assist period (Figure 2).
Hemoglobin levels were significantly decreased at 8
hours even though fresh, heparinized whole blood was
administered to replace measurable blood loss. The decline
in serum hemoglobin was attributed to unquantified blood
loss and a mild dilutional effect from crystalloid adminis-
tration. The pH remained within the normal range despite a
statistically significant decrease at 8 hours. Gas exchange
function remained excellent in all cases. Ventilator adjust-
ments did not deviate more than 10% from baseline settings,
and peak airway pressures remained less than 25 cm H2O.
Figure 1. Total cavopulmonary diversion using bicaval venous–to–pulmonary artery cannulation. A miniature
centrifugal pump was used to augment cavopulmonary flow. A decompression cannula was placed into the right
ventricle to divert thebesian and coronary venous blood to the low-pressure systemic venous circulation. The
proximal main pulmonary artery was clamped to exclude right ventricular contribution to pulmonary blood flow.
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Neither pulmonary edema nor hemorrhage was observed.
High partial pressures of oxygen were maintained without
acute compromise in circulatory stability.
Discussion
This study demonstrates relative hemodynamic stability in a
neonatal animal model of pump-assisted cavopulmonary
TABLE 1. Hemodynamic and gas-exchange data with newborn cavopulmonary assist
Parameter Baseline
1-h
cavopulmonary
assist
8-h
cavopulmonary
assist P value
Heart rate (bpm) 188 26 189 37 172 34
Systolic blood pressure 73 12 70 15 72 16
Diastolic blood pressure 41 10 32 10 26 7† .002
Pulmonary artery pressure 13.1 2.1 21.2 3.1* 23.3 4.3* .001
Left atrial pressure 3.5 1.8 4.2 1.3 5.2 1.5* .025
Inferior vena caval pressure 4.3 1.8 5.2 1.3 7.8 2.4* .001
MCFP (n  5) 8 1.8 11 2.4* .021
Cardiac index 4.45 1.53 4.14 1.33 4.38 1.04
Systemic blood flow 253.9 84.0 238.9 86.8 251.8 69.0
Pulmonary vascular resistance 3.24 1.09 6.22 2.13* 5.94 1.29* .001
Lactate (mmol/L) 3.06 1.24 3.98 2.26 5.88 4.14
Hemoglobin (g/dL) 9.7 2.4 9.2 2.1 7.4 1.6† .019
pH 7.47 0.15 7.48 0.07 7.38 0.07† .043
PCO2 (mm Hg) 32.9 9.7 28.4 6.1 35.3 5.7
PO2 (mm Hg) 442.8 91.4 449.8 125.2 447.4 124.4
HCO3
 (mmol/L) 24 4 21 4 20 3* .038
Base excess (mmol/L) 0.8 4.6 1.4 3.9 3.8 3.3* .020
Baseline refers to conditions before cavopulmonary diversion. Cavopulmonary assist data are shown at 1- and 8-hour periods after initiation of
cavopulmonary assist. Values are expressed as mean  SD in 13 lambs. Pressures are in mm Hg. Cardiac index is expressed as L/min/m2. Systemic
blood flow is calculated as cardiac output/weight and is expressed as mL · min1 · kg1. Pulmonary vascular resistance is calculated as (PPA  PLA)/SBF
and expressed as 103 dyn · s · cm5 · kg1. MCFP, Mean circulatory filling pressure; SBF, systemic blood flow; PPA, mean pulmonary artery pressure; PLA,
mean left atrial pressure.
*Significantly different from baseline, †significantly different from baseline and the 1-hour cavopulmonary assist period.
Figure 2. Cardiac index and pulmonary vascular resistance versus time (B, baseline). Time 0 indicates the
commencement of cavopulmonary assist. Cardiac index remained statistically unchanged throughout the study.
Pulmonary vascular resistance, although initially increased, trended downward and was significantly lower at
time 8 compared with times 2 and 3. All cavopulmonary assist time points were significantly different from baseline
(P < .003). *Significant difference from the 8-hour time point (P < .039); significant difference from time 0 (P 
.043). Error bars represent SD.
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blood flow when compared with prior similar models of
univentricular circulation in which cavopulmonary support
was not applied.12,13 Heart rate, systolic blood pressure, and
cardiac index remained at baseline levels. The significant
decrease in diastolic blood pressure and increase in left
atrial pressure, a reflection of diminished left ventricular
function, are attributable to extensive surgical intervention,
vasoactive and myocardial depressive effects of chronic
inhaled anesthetic, and withholding inotropic support.
Slight increases in inferior vena caval pressure and mean
circulatory filling pressure are consistent with mild volume
loading. The systemic venous pressure increases in this
study were minimal compared with previous experimental
models of Fontan circulation without mechanical assistance,
in which a central venous pressure of more than 20 to 25
mm Hg was required to overcome the cavopulmonary pres-
sure gradient and provide adequate preload to the systemic
ventricle.
Arterial lactate, base excess, and pH measurements in-
dicate a trend toward metabolic acidosis over the course of
the study. This suggests suboptimal systemic perfusion, but
it did not affect overall hemodynamic stability. Baseline
cardiac output in this model likely underestimates basal
cardiac output in awake animals due to myocardial depres-
sant effects of inhaled anesthetic. Because cavopulmonary
assist pump output was matched to baseline cardiac output
in the cavopulmonary assist period, this possibly contrib-
uted to inadequate systemic perfusion. The addition of ino-
tropic support to maintain ventricular function could alle-
viate the problem of inadequate systemic perfusion.
Pulmonary artery pressures and pulmonary vascular re-
sistance increased significantly from baseline after pump
flow was instituted. This was not unexpected given the high
pulmonary vascular reactivity of the neonate, the presence
of mild metabolic acidosis, and the continuous nature of
pulmonary blood flow in contrast to physiologic pulsatile
flow.14,15 Actual increases in pulmonary artery pressures
were modest (30% systemic pressure), and no extended
periods of pulmonary hypertension (50% systemic pres-
sure) were observed. Furthermore, pulmonary vascular re-
sistance decreased significantly through the last 6 hours of
the study. The use of pulmonary vasodilators could lessen
absolute pulmonary pressures to more closely approximate
baseline.
An assumption that a reactive newborn pulmonary vas-
culature will yield a transpulmonary gradient prohibitive to
Fontan circulation may be inaccurate if ideal cavopulmo-
nary flow conditions are provided. In healthy neonates,
pulmonary vascular resistance decreases precipitously to
within 10% of adult baseline values within hours after birth
and is maintained at these low levels despite the presence of
the reactive transitional pulmonary substrate.16 The paradox
of the Fontan circulation is that it produces simultaneous
vena caval hypertension and pulmonary arterial hypoten-
sion.17 Theoretically, minimal hydraulic support would be
required to overcome the 10 to 20 mm Hg cavopulmonary
pressure gradient needed to augment flow from the systemic
venous circulation to the pulmonary circulation and reverse
the paradox. Implantable devices that have been developed
for systemic circulatory support are capable of performing
this task and may make it possible to overcome the poten-
tially increased pulmonary vascular resistance of the neo-
nate.
There are several compelling theoretical advantages un-
derlying the rationale for cavopulmonary assist (Figure 3).
Most importantly, the univentricular circulation is restored
to one resembling 2-ventricle physiology with a series ar-
rangement of the pulmonary and systemic circulations. The
single ventricle is not subjected to volume overload and
must pump only 1 ventricular output while a device sup-
ports the equivalent of right ventricular output. An early
reduction of volume work has demonstrated benefit to long-
term myocardial function for single-ventricle physiolo-
gy.18,19 Coronary perfusion pressure, which is dependent on
diastolic blood pressure, could theoretically be preserved.8
Partial pressure of oxygen can be maintained within the
physiologically normal range without inducing circulatory
balance instability, as seen in classic Norwood physiology.
Fully oxygenated blood (PO2 80 mm Hg) improves myo-
cardial performance, optimizes function of highly oxygen-
dependent organ systems (eg, brain and kidney), and min-
imizes pulmonary vascular resistance, thus indirectly
reducing the circulatory support requirement. Finally, the
transitional pulmonary vasculature is not exposed to hypox-
emia, and this prevents pathologic pulmonary vascular re-
modeling.6
This work introduces several novel physiologic concepts.
The first is the effect of cavopulmonary assist on chronic
maturation of the newborn transitional pulmonary vascula-
ture. The second is the response of the newborn systemic
venous circulation to a gradual transition to Glenn or Fontan
physiology. The third is technical issues related to applica-
tion of this type of circulatory support in a neonate, includ-
ing duration of support, potential benefit of pulsatile perfu-
sion, risk of thrombosis, and growth potential of surgical
pathways.
This work is highly theoretical, and any application to
the clinical arena remains speculative. The concept could be
applied either to partial (Glenn) cavopulmonary diversion or
to total (Fontan) cavopulmonary diversion. The study is
limited by the absence of true single-ventricle anatomy, and
the functional ventricle is a morphologically left ventricle.
One hundred percent inspired oxygen was used to show
circulatory stability at high blood oxygen concentrations;
this is not observed in stage 1 Norwood physiology. The
decrease in diastolic blood pressure cannot be attributed to
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an anatomic cause, however, and, on the basis of our results,
does not seem to be due to inadequate preload to the single
ventricle or to low cardiac output. This is a serious limita-
tion that seems to be related to the anesthetic regimen, a
conservative fluid management strategy, and a lack of ino-
tropic support in an intricate neonatal model of univentricu-
lar circulation. The steady flow conditions provided by the
pump may have had detrimental effects on the pulmonary
vasculature in comparison to pulsatile flow, and this will
require additional study. Despite these limitations, this
study demonstrates the feasibility of cavopulmonary assist
in maintaining relative stability in an acute experimental
model of newborn total cavopulmonary diversion and uni-
ventricular circulation.
Figure 3. Theoretical circulatory energetics of cavopulmonary assist. Pressure-time diagrams schematically
illustrate the work function of various physiologic states. A, Normal circulation. B, Norwood circulation. Of note
are a parallel arrangement of the systemic and pulmonary circulations, increased pulmonary vascular resistance,
and volume load on the single ventricle. C, Fontan circulation. The systemic and pulmonary circulations are in
series. D, Cavopulmonary assist; replicates 2-ventricle physiology (in comparison to A). E, The circulation as
cavopulmonary assist is being weaned. With decreasing support, systemic venous pressure increases and
pulmonary arterial pressure decreases to converge at equilibrium. Pulmonary vascular resistance is a principal
determinant of the equilibrium point, and a lower value portends more favorable Fontan hemodynamics. F, The
circulation after cavopulmonary assist has been weaned. This is similar to the Fontan circulation shown in C. The
dashed line represents postulated increased work resulting from pulmonary vascular maladaptation following the
classic staged surgical approach. The area between the 2 curves, denoted by a-a', represents a theoretical
work-reduction benefit to the single ventricle, assuming that the pulmonary vasculature matures more normally
under conditions of cavopulmonary assist. LV, Left ventricle; RV, right ventricle; SV, single ventricle; Ao, aorta; PA,
pulmonary artery; LA, left atrium; Rs , systemic vascular resistance; Rp , pulmonary vascular resistance.
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